This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of the specialty drug Skyrizi (600 mg/10 ml vial). The contract, valued at $11,921.68, has an ultimate completion date of December 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of the larger DLA IDC that enables efficient government procurement of essential pharmaceutical and medical supplies for the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/6/25, 9:28 AM